This application relates to cellular based-therapies for increasing the levelofRegulatory T cells and/or decreasing the level of pro-inflammatory T cells toinduceanergy or immune tolerance. To provide these therapeutic effects, a polymer-modifiedleukocyte is contacted with a second immunogenic leukocyte. Cellularpreparationsand processes for achieving cellular therapy are also provided.